Gene · 1293
Papers2,433
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,433
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of circulating proteins associated with general cognitive function among middle-aged and older adults. | Commun Biol | 2023 | 37923804 | PubTator, text mining | PubMed |
| Progressive insights into fibrosarcoma diagnosis and treatment: leveraging fusion genes for advancements. | Front Cell Dev Biol | 2023 | 37920823 | PubTator, text mining | PubMed |
| Uneven Expression of 20 Human Papillomavirus Genes Associated with Oropharyngeal Carcinoma. | Rambam Maimonides Med J | 2023 | 37917867 | PubTator, text mining | PubMed |
| Combining single-cell RNA sequencing and population-based studies reveals hand osteoarthritis-associated chondrocyte subpopulations and pathways. | Bone Res | 2023 | 37914703 | PubTator, text mining | PubMed |
| Current Knowledge on the Interaction of Human Cytomegalovirus Infection, Encoded miRNAs, and Acute Aortic Syndrome. | Viruses | 2023 | 37896804 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing of 24 Spanish Families: Candidate Genes for Non-Syndromic Pediatric Keratoconus. | Genes (Basel) | 2023 | 37895187 | PubTator, text mining | PubMed |
| Basement Membrane-Associated lncRNA Risk Model Predicts Prognosis and Guides Clinical Treatment in Clear Cell Renal Cell Carcinoma. | Biomedicines | 2023 | 37893009 | PubTator, text mining | PubMed |
| Pharmacotherapeutic Approaches to Treatment of Muscular Dystrophies. | Biomolecules | 2023 | 37892218 | PubTator, text mining | PubMed |
| Limited Hyperoxia-Induced Proliferative Retinopathy (LHIPR) as a Model of Retinal Fibrosis, Angiogenesis, and Inflammation. | Cells | 2023 | 37887312 | PubTator, text mining | PubMed |
| CNS tumor stroma transcriptomics identify perivascular fibroblasts as predictors of immunotherapy resistance in glioblastoma patients. | NPJ Genom Med | 2023 | 37884531 | PubTator, text mining | PubMed |
| COL3A1, COL5A1 and COL6A2 serve as potential molecular biomarkers for osteoarthritis based on weighted gene co‑expression network analysis bioinformatics analysis. | Exp Ther Med | 2023 | 37869636 | PubTator, text mining | PubMed |
| PIK3CD correlates with prognosis, epithelial-mesenchymal transition and tumor immune infiltration in breast carcinoma. | Discov Oncol | 2023 | 37861728 | PubTator, text mining | PubMed |
| The entanglement of extracellular matrix molecules and immune checkpoint inhibitors in cancer: a systematic review of the literature. | Front Immunol | 2023 | 37854588 | PubTator, text mining | PubMed |
| Machine learning developed a PI3K/Akt pathway-related signature for predicting prognosis and drug sensitivity in ovarian cancer. | Aging (Albany NY) | 2023 | 37851341 | PubTator, text mining | PubMed |
| Brain Metastases from Breast Cancer Histologically Exhibit Solid Growth Pattern with at Least Focal Comedonecrosis: A Histopathologic Study on a Monocentric Series of 30 Cases. | Diagnostics (Basel) | 2023 | 37835885 | PubTator, text mining | PubMed |
| A Novel Role of Connective Tissue Growth Factor in the Regulation of the Epithelial Phenotype. | Cancers (Basel) | 2023 | 37835529 | PubTator, text mining | PubMed |
| Biomarkers for Immunotherapy in Driver-Gene-Negative Advanced NSCLC. | Int J Mol Sci | 2023 | 37833968 | PubTator, text mining | PubMed |
| Bioinformatics analysis of competing endogenous RNA network in decidual natural killer cell from unexplained recurrent spontaneous abortion. | Medicine (Baltimore) | 2023 | 37832104 | PubTator, text mining | PubMed |
| Editorial: Tumor microenvironment and cancer therapy. | Front Cell Dev Biol | 2023 | 37808077 | PubTator, text mining | PubMed |
| ERRγ agonist under mechanical stretching manifests hypertrophic cardiomyopathy phenotypes of engineered cardiac tissue through maturation. | Stem Cell Reports | 2023 | 37802074 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1293/papers?page=13